{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:21:26Z","timestamp":1761513686570},"reference-count":3,"publisher":"Scientific Scholar","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0378-6323.163800","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T03:53:29Z","timestamp":1441079609000},"page":"540","source":"Crossref","is-referenced-by-count":2,"title":["Topical mTOR (mechanistic target of rapamycin) inhibitor therapy in facial angiofibroma"],"prefix":"10.25259","volume":"81","author":[{"given":"Debopam","family":"Samanta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.163800-1","first-page":"23","volume-title":"Analysis of twenty pediatric cases of tuberous sclerosis complex: Are we doing enough?","author":"Nath","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"http:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.163800-2","first-page":"888","volume-title":"Facial Angiofibroma Severity Index (FASI): Reliability assessment of a new tool developed to measure severity and responsiveness to therapy in tuberous sclerosis-associated facial angiofibroma","author":"Salido-Vallejo","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0378-6323.163800-3","first-page":"109","volume-title":"Topical everolimus for facial angiofibromas in the tuberous sclerosis complex.A first case report","author":"Dill","year":"2014","journal-title":"Pediatr Neurol"}],"container-title":["Indian Journal of Dermatology, Venereology, and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:38:38Z","timestamp":1612658318000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/topical-mtor-mechanistic-target-of-rapamycin-inhibitor-therapy-in-facial-angiofibroma\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":3,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"alternative-id":["163800"],"URL":"https:\/\/doi.org\/10.4103\/0378-6323.163800","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}